RGNX Competitors & Alternatives
Compare Regenxbio Inc with similar stocks in the same industry
Biotechnology
RGNX
Main Stock$8.38
Tradestie Score
56
Market Cap
$493.52M
Revenue Growth
0.4%
Analyst Upside
+232.2%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.99
|
$474.20M | 28.7 | 53 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$4.76
|
$468.01M | - | 53 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$18.94
|
$463.20M | - | 60 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$7.19
|
$457.09M | - | 48 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$3.59
|
$454.29M | - | 60 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$16.30
|
$448.32M | - | 57 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$23.61
|
$422.50M | - | 56 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$87.90
|
$410.79M | - | 59 | Compare |
More RGNX Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry